网赌正规靠谱平台

  

Department of Pathogenic Biology and Immunology

  

The Department of Pathogenic Biology and Immunologyis one of the pre-clinical departments in theMedical School, Southeast University. In 2001, the Department wasorganized by Department of Microbiology, Department of Immunology, and Department Parasitology. The department has a total of 15 faculty members, including 4 professors (4 being PhD supervisors),5 associate Professors (1 being PhD supervisor and 3 being MD supervisors),4 lecturers, and2 experimental engineers. Immunology belongs to the Key Discipline of Medical School, which has been eligible to confer doctoral degrees since 2005. Microbiology was granted the right to confer master degree since 1989.

The department undertook more than 20 research projects funded by the National Natural Science Foundation, and many provincial and ministerial research projects. A part of faculty have served asPrinciple Investigator for participating in the 863 project, the 973 project, the 2011 project, and the National key researchspecial project.Over the past 5 years, the department has educated and trained more than 70 PhD and MD students, and has received 2 provincial awards, and published more than 100 papers including 80 SCI papers.

Main characteristics and advantages:

1. Tumor immunology & Tumor stem cells: research on the biology of tumor cells and tumor stem cells, the investigation of the tumorheterogeneity and its microenvironment, and the discovery of a novel immunological therapeutic methodsfor effective treatment of tumorsand eradicating seeds of malignant tumor cells.

  

2.Tumor biomarkers & New techniques in immunological diagnose: research onthe tumor specific biomarkers and molecular targets using a new type of techniques includingmanipulation of ncRNAs and nanotheranostics, to explore the measures for blocking the critical signal pathways of tumor cellaberrant proliferation and self-renewal.

  

3. Infection immunity & Vaccine development: research on themicroorganism infection immunity, screening drug-resistance of target genes, and the discovery of the key dominant antigen for vaccine development.

  

Director: Dou, Jun, M.D., Ph.D.

Deputy Director: Shen, Chuanlai, M.D., Ph.D.

Contact: 025-83272506, 025-83272454

 

 

XML 地图 | Sitemap 地图